scholarly journals A Low-Carbohydrate Diet Realizes Medication Withdrawal: A Possible Opportunity for Effective Glycemic Control

2021 ◽  
Vol 12 ◽  
Author(s):  
Yuxin Han ◽  
Bingfei Cheng ◽  
Yanjun Guo ◽  
Qing Wang ◽  
Nailong Yang ◽  
...  
Keyword(s):  
Body Weight ◽  
Blood Glucose ◽  
Glycemic Control ◽  
Lipid Lowering ◽  
Chinese Government ◽  
Carbohydrate Diet ◽  
Low Carbohydrate Diet ◽  
Significant Difference ◽  
Low Carbohydrate ◽  
Lipid Lowering Agents

ObjectiveMultiple studies have confirmed that diet restrictions can effectively realize glycemic control and reduce metabolic risks in patients with type 2 diabetes mellitus (T2DM). In 2018, the American Diabetes Association (ADA) and European Association for the Study of Diabetes (EASD) stated that individuals can select a low-carbohydrate diet (LCD) according to their needs and preferences. Owing to the influence of Chinese traditional eating habits, only a small portion of patients in China have achieved their blood glucose goals. As a result, the Chinese government will incur huge expenditures.MethodThis study recruited 134 T2DM participants and randomly assigned them to the LCD group (n = 67) or the low-fat diet (LFD) group (n = 67). All of the patients had a fixed amount of exercise and were guided by clinicians. After a period of dietary washout, all of the patients received corresponding dietary education according to group. The follow-up time was 6 months. The indicators for anthropometry, glycemic control, and medication application parameters were collected and compared between the two groups.ResultsThere were 121 participants who finally entered the study. The proportions of calories from three major nutrients the participants consumed met the requirements of LCD and LFD. Compared with baseline, the pre-postdifferences of body weight, BMI, and several other indicators were significant except for dosages of insulin used in the LCD group and MES in the LFD group. After the intervention, body weight, body weight index (BMI), fasting blood glucose (FBG), postprandial 2-h blood glucose (PPG), and glycosylated hemoglobin (HbA1c) levels in the LCD group decreased significantly (p < 0.05) compared with the LFD group. The number of patients using lipid-lowering agents was significant higher in the LCD group and lower in the LFD group. However, there was no significant difference between the two groups for antihypertensive, hormone-replacement, and other agents.ConclusionsThe LCD diet can decrease body weight, glycemic levels, MES, and lipid-lowering agents more than the LFD diet, thus decreasing cost burden in Chinese patients with T2DM. Strict diet control and monitoring are the keys to managing diabetes.

scholarly journals Alternate Day Fasting Combined with a High Protein/low Carbohydrate Diet: Effect on Body Weight and Metabolic Disease Risk Factors in Obese Adults (P21-018-19)

2019 ◽  
Vol 3 (Supplement_1) ◽  
Author(s):  
Faiza Kalam ◽  
Kelsey Gabel ◽  
Eric Wiseman ◽  
Krista Varady
Keyword(s):  
Blood Pressure ◽  
Body Weight ◽  
Fat Mass ◽  
Disease Risk ◽  
High Protein ◽  
Obese Adults ◽  
Carbohydrate Diet ◽  
Low Carbohydrate Diet ◽  
Low Carbohydrate ◽  
Alternate Day Fasting

Abstract Objectives This pilot study is the first to examine the impact of alternate day fasting (ADF) combined with a high protein/low carbohydrate diet on body weight and metabolic disease risk factors in obese adults. Methods Obese adults (n = 10) followed an ADF diet (600 kcal fast day alternated with an ad libitum feast day; 35% protein, 22% carbohydrate, 43% fat) for 6 months. Meal replacements were consumed on the fast and feast days, in addition to regular foods, to help attain macronutrient targets. Results Body weight decreased (P < 0.001) by 8.4 ± 1.7 kg (8.6 ± 1.7%) after 6 months. Fat mass and visceral fat mass were reduced (P < 0.05) by 6.4 ± 1.6 kg and 0.2 ± 0.1 kg, respectively. Lean mass decreased (P < 0.05) by 1.3 ± 0.6 kg. Systolic blood pressure was reduced (P < 0.05) by 10 ± 3 mm Hg, and diastolic blood pressure was reduced (P < 0.05) by 6 ± 3 mm Hg. Fasting glucose, insulin, insulin resistance, and HbA1c remained unchanged after 6 months of diet. LDL cholesterol and triglyceride levels decreased (P < 0.001) by10 ± 4% and 15 ± 8%, respectively, after 6 months. HDL cholesterol levels decreased by 6 ± 3% from baseline to post-treatment. Conclusions These preliminary findings suggest that ADF combined with a high protein/low carbohydrate diet is effective for lowering body weight, visceral fat mass, blood pressure, LDL cholesterol and triglyceride levels. However, this diet has no effect on glucoregulatory factors. While these preliminary findings are promising, they still require confirmation by a larger-scale clinical trial. Funding Sources Nestle Health Sciences Grant.

Treatment of Newly Diagnosed Diabetic Cats with Glargine Insulin Improves Glycaemic Control and Results in Higher Probability of Remission than Protamine Zinc and Lente Insulins

2009 ◽  
Vol 11 (8) ◽  
pp. 683-691 ◽  
Author(s):  
R.D. Marshall ◽  
J.S. Rand ◽  
J.M. Morton
Keyword(s):  
Blood Glucose ◽  
Glycaemic Control ◽  
Daily Treatment ◽  
Newly Diagnosed ◽  
Carbohydrate Diet ◽  
Glargine Insulin ◽  
Low Carbohydrate Diet ◽  
Good Glycaemic Control ◽  
Low Carbohydrate ◽  
Blood Glucose Concentrations

Glycaemic control and remission probabilities were compared in 24 newly diagnosed diabetic cats treated twice daily with either glargine, protamine zinc (PZI) or lente insulin and fed a low carbohydrate diet. After day 17, the probability of remission was substantially higher for cats with lower mean 12 h blood glucose concentrations on day 17, irrespective of insulin type. Glargine-treated cats had lower mean 12 h blood glucose concentrations on day 17 than PZI- or lente-treated cats, and all eight glargine-treated cats achieved remission compared to three PZI- and two lente-treated cats. The probability of remission was greater for cats treated with glargine than cats treated with PZI or lente insulin. In newly diagnosed diabetic cats, twice daily treatment with glargine provides better glycaemic control and higher probability of remission compared to twice daily treatment with PZI or lente insulin. Good glycaemic control soon after diagnosis is associated with increased probability of remission and should be the goal of insulin therapy.

scholarly journals The possible mediatory role of adipokines in the association between low carbohydrate diet and depressive symptoms among overweight and obese women

PLoS ONE ◽  
2021 ◽  
Vol 16 (9) ◽  
pp. e0257275
Author(s):  
Leila Setayesh ◽  
Reyhane Ebrahimi ◽  
Sara Pooyan ◽  
Habib Yarizadeh ◽  
Elaheh Rashidbeygi ◽  
...  
Keyword(s):  
Depressive Symptoms ◽  
Transforming Growth Factor ◽  
Enzyme Linked Immunosorbent Assay ◽  
Carbohydrate Diet ◽  
Low Carbohydrate Diet ◽  
Significant Difference ◽  
Low Carbohydrate ◽  
Galectin 3 ◽  
Pai 1

Background Previous studies showed the possible association between obesity, dietary pattern, and depressive symptoms. Due to the lack of enough data to confirm the association of obesity and depression in the Middle East, here, we aimed to explore the possible mediatory role of adipokines Galectin-3, transforming growth factor-beta (TGF-β), and endothelial plasminogen activator inhibitor (PAI-1) in the association between low carbohydrate diet (LCD) and depressive symptoms. Methods A total of 256 women aged 17–56 years old were grouped based on their LCD score. Depression anxiety stress scales-21 (DASS-21) self-administered questionnaire was used to evaluate the three negative emotional states of stress, depressive symptoms, and anxiety. Body composition and dietary intake were assessed. Enzyme-linked immunosorbent assay (ELISA) was used to measure the serum levels of Galectin-3, TGF-β, and PAI-1. Results No significant difference was observed regarding Galectin-3, TGF-β, and PAI-1 levels between the groups with dissimilar adherence to LCD or the groups with different levels of depressive symptoms (P>0.05). However, there was a negative association between LCD score as a covariant and depressive symptoms as an independent variable (P = 0.02) and remarkably, a regression model linear analysis using Galectin-3, TGF-β, and PAI-1 as confounding variables indicated the mediatory role of these adipokines in this association (P>0.05). In other words, adipokines eliminated the significance of the relationship between adherence to LCD and depressive symptoms. Conclusion It seems that higher adherence to LCD is probably associated with a lower prevalence of depressive symptoms in obese adults through the mediatory role of adipokines.

scholarly journals Urinary C-Peptide Excretion for Diabetic Treatment in Low Carbohydrate Diet (LCD)

2018 ◽  
pp. 13-18 ◽  
Author(s):  
Hiroshi Bando ◽  
Koji Ebe ◽  
Tetsuo Muneta ◽  
Masahiro Bando ◽  
Yoshikazu Yonei
Keyword(s):  
Diabetes Mellitus ◽  
Blood Glucose ◽  
Glucose Variability ◽  
Carbohydrate Diet ◽  
C Peptide ◽  
Low Carbohydrate Diet ◽  
Low Carbohydrate ◽  
Diabetic Treatment ◽  
Average Glucose

Background: Arguments have continued about Low Carbohydrate Diet (LCD) and Calorie Restriction (CR). Authors have reported clinical research of LCD and Morbus (M) value. Subjects and Methods: Subjects enrolled are 84 patients with Type 2 diabetes mellitus (T2DM), 60.9 ± 10.9 years. The protocol were as follows: 1) CR diet on day 1, 2 with 60% carbohydrates, and LCD on day 3-14 with 12% carbohydrates, 2) Daily profile of blood glucose 7 times a day on day 2 (CR) and day 4 (LCD), 3) urinary C-Peptide radioimmunoassay (u-CPR) excretion, 4) M value calculation, 5) investigation of these data with correlation. Results: Subjects were classified into 4 groups according to M value, which were .4–21, 23–66, 29–192, 200–728, respectively. HbA1c value was 6.2, 8.0, 7.8, 9.2 %, respectively. Blood glucose in median from day 2 to day 4 were 123 to 107 mg/dL, 164 to 130 mg/dL, 193 to 156 mg/dL, 277 to 201 mg/dL, respectively. M value in median from day 2 to 4 was 6.3 to 9, 41 to 7, 108 to 16, 367 to 88, respectively. u-CPR was 88 to 58, 53 to 35, 65 to 52, 74 to 64, respectively. There were significant correlations among among glucose, M value and u-CPR. Discussion and Conclusion: Average glucose, M value and u-CPR decreased remarkably on day 4. As average glucose and M value were higher, decrease degree were larger. These results suggested that carbohydrate in meal would influence glucose variability in T2DM. Our data would become basic data for pathophysiological analysis of glucose variability research in the future.

scholarly journals A Low-Carbohydrate Diet Improves Glucose Metabolism in Lean Insulinopenic Akita Mice Along With Sodium-Glucose Cotransporter 2 Inhibitor

2020 ◽  
Vol 11 ◽  
Author(s):  
Yukihiro Fujita ◽  
Kuralay K. Atageldiyeva ◽  
Yasutaka Takeda ◽  
Tsuyoshi Yanagimachi ◽  
Yuichi Makino ◽  
...  
Keyword(s):  
Body Weight ◽  
Gene Expressions ◽  
Carbohydrate Diet ◽  
Glucose Levels ◽  
Low Carbohydrate Diet ◽  
Chronic Hyperglycemia ◽  
Islet Morphology ◽  
Sodium Glucose Cotransporter ◽  
Low Carbohydrate ◽  
Akita Mice

ObjectiveA low-carbohydrate diet (LC) can be beneficial to obese subjects with type2 diabetes mellitus (T2DM). Sodium-glucose cotransporter 2 inhibitor (SGLT2i) presents prompt glucose-lowering effects in subjects with T2DM. We investigated how LC and SGLT2i could similarly or differently influence on the metabolic changes, including glucose, lipid, and ketone metabolism in lean insulinopenic Akita mice. We also examined the impacts of the combination.MethodsMale Akita mice were fed ad libitum normal-carbohydrate diet (NC) as a control or low-carbohydrate diet (LC) as an intervention for 8 weeks with or without SGLT2i treatment. Body weight and casual bold glucose levels were monitored during the study, in addition to measuring TG, NEFA, and ketone levels. We quantified gene expressions involved in gluconeogenesis, lipid metabolism and ketogenesis in the liver and the kidney. We also investigated the immunostaining analysis of pancreatic islets to assess the effect of islet protection.ResultsBoth LC and SGLT2i treatment reduced chronic hyperglycemia. Moreover, the combination therapy additionally ameliorated glycemic levels and preserved the islet morphology in part. LC but not SGLT2i increased body weight accompanied by epididymal fat accumulation. In contrast, SGLT2i, not LC potentiated four-fold ketone production with higher ketogenic gene expression, in comparison with the non-treated Akita mice. Besides, the combination did not enhance further ketone production compared to the SGLT2i alone.ConclusionsOur results indicated that both LC and SGLT2i reduced chronic hyperglycemia, and the combination presented synergistic favorable effects concomitantly with amelioration of islet morphology, while the combination did not enhance further ketosis in Akita mice.

Introducing a very low carbohydrate diet for a child with type 1 diabetes

2019 ◽  
Vol 28 (15) ◽  
pp. 1015-1019
Author(s):  
Caroline de Souza Bosco Paiva ◽  
Maria Helena Melo Lima
Keyword(s):  
Type 1 Diabetes ◽  
Blood Glucose ◽  
Glycated Haemoglobin ◽  
Healthy Weight ◽  
Carbohydrate Diet ◽  
Glucose Levels ◽  
Low Carbohydrate Diet ◽  
Low Carbohydrate ◽  
Continuous Glucose Monitors

Type 1 diabetes mellitus is a serious autoimmune disease for which no cure is available. The treatment includes insulin therapy, carbohydrate counting, eating healthy foods, exercising regularly, and maintaining a healthy weight. The goal is to keep blood glucose levels close to normal most of the time to delay or prevent complications. Despite the increase in the use of insulin pumps and continuous glucose monitors in recent years, the management of type 1 diabetes remains suboptimal in terms of glycaemic control and normal glycated haemoglobin (HbA1c) level. This article discusses the case of a child with type 1 diabetes who was successfully treated with a very low-carbohydrate diet, resulting in normal levels of HbA1c and normal blood glucose 95% of the time in a range of 70–180 mg/dL (4.0 mmol/L−10 mmol/L). Therefore, further studies are needed to verify how a very low carbohydrate diet impacts child development.

Sign in / Sign up

Export Citation Format

Share Document